Novo Nordisk A/S (NOVO-B.CO) rose 5.6% on 4 Nov 2026. The stock closed at DKK 285.20, against DKK 270.15 the session before.
That puts the company's market value at about DKK 1.3T. The 52-week range is DKK 224.25 to DKK 409.95, so the stock now sits 30.4% below the top of it.
Over the past 52 weeks the shares have moved −10.3%.
Figures from Yahoo Finance at the time of writing. Not investment advice.